Health
Weight-based dosing strategy may affect immunotherapy outcomes, shows study – News-Medical.Net
Overweight cancer patients receiving immunotherapy treatments live more than twice as long as lighter patients, but only when…
Overweight cancer patients receiving immunotherapy treatments live more than twice as long as lighter patients, but only when dosing is weight-based, according to a study by cancer researchers at UT Southwestern Medical Center.
The findings, published in…
Continue Reading
-
Noosa News13 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
General22 hours agoProductivity summit ends day two with progress on rules changes to boost housing supply
-
Noosa News19 hours agoChilling new details emerge in terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
Noosa News19 hours agoThe key industries on the rise as Brisbane economy hits $200b